Ti Pharma

Jointly shaping the future of medicines

  • Contact
 
  • Home
  • About our institute
  • Research Program
  • Projects
  • Education & Training
  • Careers
  • News
  • Events
  • Calendar
  • Contact
Log in

You are here:

  1. TI Pharma
  2. Calendar

Calendar

Select a category:
January
March
April
May
June
July
September
October
December

Calendar

  • 15 03 2012 Health Valley
  • 19 03 2012 Bio Europe Spring, Amsterdam
  • 28 03 2012 PCDI Postdoc Retreat 2012 for Life Sciences
  • 17 04 2012 TI Pharma Spring Meeting 2012
  • 24 05 2012 1st Annual International Conference on Genomics: ICG Europe 2012
  • 30 05 2012 European Lab Automation 2012
  • 01 10 2012 FIGON Dutch Medicines Days 2012
© 2012 TI Pharma, Galileiweg 8, 2333 BD Leiden, The Netherlands, Tel.: 071-332-2030
  • Home
  • About our institute
    • Organizational structure
    • Our partners
    • Our vision
    • Our mission
    • The Dutch landscape
  • Research Program
    • euSEND
    • Strategic Research Program
    • Priority Medicines
    • Prizes & Awards
    • Theses
  • Projects
    • (Auto-) Immune Diseases
    • Brain Diseases
    • Cardiovascular Diseases
    • Cancer
    • Infectious Diseases
    • Efficiency Analysis Drug Discovery Process
    • Target Finding, Validation, and Animal Models
    • Lead Selection and in silico Modeling
    • Predictive Drug Disposition and Toxicology
    • Biomarkers and Bio-sensoring
    • Drug Formulation, Delivery and Targeting
    • Pharmaceutical Production Technologies
  • Education & Training
    • Education & Training
    • Course Catalogue
  • Careers
    • Vacancies
    • Applications
  • News
    • News Overview
    • News Archive
    • Newsletters
    • Annual Reports
    • ISRC Reports
  • Events
    • Upcoming Events
    • Past Events
  • Calendar
  • Contact
    • Address and route
    • Contactform
  • Organizational structure
    • Supervisory Board
    • Executive Board
    • Management Team
    • International Scientific Review Committee
  • Our partners
  • Our vision
  • Our mission
  • The Dutch landscape
  • euSEND
  • Strategic Research Program
  • Priority Medicines
  • Prizes & Awards
  • Theses
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
  • Education & Training
    • Biologicals
    • Drug Discovery & Development Cycle (DDC)
    • Business & Entrepreneurial Skills (BES)
    • Drug Discovery Simulation (DDIS)
    • Drug Development Simulation (DDES)
    • Intellectual Property (IP)
    • Project Management (PM)
    • Industry Day (IND)
  • Course Catalogue
  • Vacancies
  • Applications
  • News Overview
  • News Archive
  • Newsletters
  • Annual Reports
  • ISRC Reports
  • Upcoming Events
  • Past Events
  • Address and route
  • Contactform
  • (Auto-) Immune Diseases
    • CXC Chemokine receptors
    • Insuline resistance
    • COPD and smoking
    • Systemic inflammation
    • Osteoarthritis
    • Immune modulation
    • Neuromodulation
  • Brain Diseases
    • Nanoscience and the BBB
    • Role of the endocannabinoid system
    • Measuring pain
    • Drugs for psychiatric disorders
    • Parkinson and Alzheimer disease
    • Psychosis susceptibility
    • CNS drug target validation
  • Cardiovascular Diseases
    • Drug-induced weight alteration
    • Metalloproteases
    • Nuclear receptors as targets
    • Renin blockade
  • Cancer
    • Novel kinases
    • Kinases in cancer
    • Signal transduction pathways
    • Nuclear receptors in cancer
    • Drug responses in breast cancer
    • TNF ligands in cancer
    • miRNA based therapeutics
  • Infectious Diseases
    • Monitoring Leishmania, Tuberculosis and Trachoma
    • Malaria
    • Efficient eradication
    • Effective HIV therapy
    • MRSA
    • Respiratory viruses
    • Vaccine against Chikungunya
    • Phosphodiesterase
  • Efficiency Analysis Drug Discovery Process
    • The Mondriaan Project
    • The Escher project
    • Orphan drugs registry
    • Predictive value of animal testing
  • Target Finding, Validation, and Animal Models
    • Toll-like receptors
    • GPCR Forum
    • Target residence time
  • Lead Selection and in silico Modeling
    • Cardiotoxicity
    • Metabolic stability
    • Ligand-Gated Ion Channel
    • PK-PD modeling platform
  • Predictive Drug Disposition and Toxicology
    • Safety biomarkers/ADR
  • Biomarkers and Bio-sensoring
    • CSF proteome/metabolome
  • Drug Formulation, Delivery and Targeting
    • The ProGraft study
    • Vaccine delivery
    • Lipid based drug delivery
  • Pharmaceutical Production Technologies
    • Hot medicines / Oxytocin
    • Design quality